Boiron SA (EPA:BOI)

Market Cap	521.74M
Revenue (ttm)	504.86M
Net Income (ttm)	19.37M
Shares Out	17.36M
EPS (ttm)	1.12
PE Ratio	26.94
Forward PE	19.24
Dividend	1.20 (3.99%)
Ex-Dividend Date	Jun 3, 2025

Volume	129
Average Volume	1,198
Open	30.30
Previous Close	30.05
Day's Range	30.20 - 30.30
52-Week Range	20.85 - 32.25
Beta	0.34
RSI	53.72
Earnings Date	Mar 20, 2026

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for ad...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,771
• Stock Exchange: Euronext Paris
• Ticker Symbol: BOI

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.